INSIGHTS ON DRUG DEVELOPMENT
-
![adare drug dev]( "New Approaches To Tailored Release Profiles")
New Approaches To Tailored Release ProfilesTailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.
-
![The Future Is Now: Are You Keeping Pace With Oligo Synthesis Optimization?]( "Are You Keeping Pace With Oligo Synthesis Optimization?")
Are You Keeping Pace With Oligo Synthesis Optimization?The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.
-
![CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic]( "CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic")
CAR-T Strategy In 2026: Scaling Autologous, Advancing AllogeneicAs CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.
-
![Strategies For API Solubility And Bioavailability Enhancement: Selecting Technologies And Excipients]( "Practical Formulation Strategies For Poorly Soluble APIs")
Practical Formulation Strategies For Poorly Soluble APIsPoor aqueous solubility now defines most drug candidates in development, making early screening and solid-state assessment essential to achieving reliable exposure and avoiding costly reformulation downstream.
-
Redefining OSD Development Through Foresight And Innovation2/12/2026
From early formulation challenges to scale-up and commercial readiness, proactive planning and integrated capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.
-
How Rheology Ensures Effective Quality Control5/1/2026
Rheology connects formulation science to manufacturing reality. By tracking how drugs flow and respond to stress, teams can prevent batch variability and protect dosage performance.
-
Chemoenzymatic N-glycan Conjugation Of Native mAbs Provides Homogeneous, Efficacious ADCs9/3/2026
A chemoenzymatic two-stage protocol enables DAR2 ADCs from native, non-engineered mAbs via glycan remodeling at Asn-297 and copper-free click chemistry, with in vivo efficacy outperforming a comparable marketed ADC.
-
Predicting Performance Of Lotions Through Rheological Characterization5/6/2026
Rheological testing shows how small formulation differences influence spreading, flow, and feel during use. With minimal sample volumes, these methods connect lab measurements to real‑world performance.
-
The QX700: Advanced Digital PCR System3/26/2026
Advanced digital PCR workflows provide precise, standard-free quantification. Maximize insights from small samples with seven-target multiplexing and automated steps to ensure high-throughput accuracy.
DRUG DEVELOPMENT SOLUTIONS
-
![leica-microsystems-s9-i-heo]( "Stereo Microscopes Reducing Inspection And Rework Time")
Leica S9 I Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica
-
![thermo1]( "Gibco Media And Feeds Selection Guide")
Navigate to the catalog media and supplements that work best with your specific cell line. Identify your cell line, select your medium, feed and supplements to boost titer. All designed to provide a superior outcome.
-
![GettyImages-171223483-cell-culture-microscope-assay]( "Assay Development And Screening")
We deliver custom assay development, screening, potency, and selectivity testing services for the pharmaceutical, biopharmaceutical, and agrochemical industries.
-
![leica-microsystems-stellaris-sted-hero]( "Fast Imaging Beyond The Diffraction Limit With STELLARIS STED Microscopes")
STELLARIS STED Microscope
Get faster to the truth
Our STED (stimulated emission depletion) technology joins the STELLARIS platform to provide you the fastest way of imaging beyond the diffraction limit. Obtain cutting-edge nanoscopy results in no time with astounding image quality and resolution, while protecting your sample. STED super-resolution allows you to study multiple dynamic events simultaneously, so you can investigate molecular relationships and mechanisms within the cellular context.
The seamless integration of STED and STELLARIS provides easy access to STED directly from the confocal interface, making it just a few clicks away. Now you can get more insights from your sample, because every detail matters.
-
![AI medical technology-GettyImages-2233342016]( "Get Drug Formulation Right From The Start")
OSDPredict™ uses artificial intelligence and machine learning to help sponsors proactively identify and address formulation challenges early — before they can disrupt downstream development.
